A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
University of California, San Francisco
University of California, San Francisco
City of Hope Medical Center
OHSU Knight Cancer Institute
University of South Florida
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
Case Comprehensive Cancer Center